SMi's 3D Cell Culture conference 2022 – Speakers announced

LONDON - Oct. 26, 2021 - PRLog -- SMi Group is delighted to announce the return of the successful 3D Cell Culture Conference for its 5th year, taking place on 9th and 10th February 2022 in London, UK.

The two-day agenda will focus on 'Developing Complex, Translatable and Physiologically-Relevant Celluar Models in Vitro'  which will explore advances application in 3C cell models, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.

This year, the conference will be co-chaired by Stefan Przyborski, Professor of Cell Technology, Durham university and Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and proudly sponsored by CELVIVO and Promego.

For those interested in attending, can register at http://www.3D-cellculture.com/PRlog1, early bird offer save £400 expires 29 October 2021

Guest Speaker: Suzanne Fitzpatrick, Senior Advisor for Toxicology, FDA

Industry and Pharma Speakers:

• Hansjoerg Keller, Sr Principal Scientist, Novartis IBR
• BanuPriya Sridharan, Investigator, Organoid and Cell Biology, GSK
• Caroline Archer, Associate Principal Scientist, AstraZeneca
• Freddy Van Goethem, Scientific Director - Fellow, Johnson & Johnson; Janssen
• Jason Ekert, Senior Director and Head of Complex In Vitro Models, GSK
• Julian Bahr, Senior Scientist, AstraZeneca
• Terry Van Vleet, Investigative Toxicology and Pathology, AbbVie
• Dr. Luca Frenguelli, Senior Scientist, Engitix therapeutics
• Robert Vries, CEO, Hubrecht organoid technology

3D Cell Culture Expert Speakers Include:

• Pedro Pinto, Lab lead, Urology, university of Greifswald – Medical Centre
• Dr. Elisa Budyn, Professor, Mechanical Engineering, Ecole Normale Supérieure Paris-Saclay
• louis Scampavia, Scientific Director, Sr, Scripps
• Catherine Vickers, Head of innovation, nC3Rs
• Stephen J. Fey, Founder and Chief Research Officer, CelVivo
• Anne Rios, Principal Investigator/ Head of the PMC imaging Center, the Princess Maxima Center

Key Benefits of Attending:

• Discuss the uses of advanced cell technologies to construct in vitro models of human tissues
• Explore the regulatory sciences surrounding Microphysiological systems, and their development and adoption for drug safety assessment
• Uncover the major benefits of 3D modelling in enhancing clinical translation and predictability
• Utilise 3D cell culture for High Throughput drug discovery and Content screening over traditional 2D methods
• Delve into advanced case studies looking into organ models: from organotypic lungs to liver spheroids

The full agenda and speaker line-up are available in the download brochure online at www.3D-cellculture.com/PR1

3D Cell Culture 2022
Workshops: 8 February 2022
Conference: 9-10 February 2022
Virtual Conference: Online Access Only
http://www.3D-cellculture.com/PRlog1
#SMi3DCellCulture